Arcadia Biosciences, Inc. (RKDA) Stock Price & Analysis
Arcadia Biosciences, Inc. (RKDA) rose 0.23% to USD 0.47 as of September 8, 2026 at 09:03 UTC, according to Nexqual real-time market data.
RKDA last closed at USD 0.47; the session ranged USD 0.46–0.48 on volume of 12,286 shares. Market capitalization is —, with a 52-week range of USD 0.38–6.71 (NCM). Source: Nexqual, September 8, 2026 at 09:03 UTC.
Key Statistics (as of September 8, 2026 at 09:03 UTC)
| Price | USD 0.47 |
|---|---|
| Change | ▲ 0.23% (up) |
| Previous Close | USD 0.47 |
| Open | USD 0.47 |
| Day Range | USD 0.46 – 0.48 |
| 52-Week Range | USD 0.38 – 6.71 |
| Volume | 12,286 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (RKDA)
Nexqual's technical model rates RKDA "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 09:03 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 38.46 (neutral) |
| vs SMA50 | Below (USD 0.61) |
| MACD | -0.04 (negative) |
From Arcadia Biosciences, Inc.'s Latest SEC 10-K Filing (filed 2026-03-26)
Partnerships
- On December 24, 2025, the Company received a notice from Roosevelt indicating that it was terminating the Exchange Agreement with immediate effect pursuant to the Termination Provision, as the closing of the Exchange had not occurred by the Termination Date specified in the Amendment.
- On March 28, 2025, Arcadia entered into an agreement with Bioceres Crop Solutions Corp. ("BIOX") pursuant to which BIOX agreed to transfer to the Company all rights and materials relating to certain soy traits that were included in licenses granted by the Company to BIOX in the November 2020 sale of Verdeca.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BPTH | Bio-Path Holdings, Inc. | USD 0.03 | ▲ 50% |
| VTVT | vTv Therapeutics Inc. | USD 33.35 | ▼ 0.15% |
| TENX | Tenax Therapeutics, Inc. | USD 1.94 | ▲ 4.86% |
| CFOR | CapForce Inc. | USD 5.15 | ▲ 0% |
| XBIO | Xenetic Biosciences, Inc. | USD 4.67 | ▲ 9.88% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:03 UTC. This page is informational and not investment advice.